Non-modulating essential hypertension: a subset particularly responsive to converting enzyme inhibitors - PubMed (original) (raw)
- PMID: 3003304
Non-modulating essential hypertension: a subset particularly responsive to converting enzyme inhibitors
G H Williams et al. J Hypertens Suppl. 1985 Nov.
Abstract
The goals of antihypertensive therapy are to normalize arterial pressure and to minimize pharmacological adverse effects. Recent data indicate that in general the first goal has been achieved but the second has not, resulting in a substantial non-compliance rate. There is increasing evidence, therefore, that the next major step forward in treating hypertensive patients is to link specific forms of therapy to subsets of the hypertensive population. The present article illustrates this point by describing the characteristics and therapeutic implications of a subset of essential hypertensives termed non-modulators and the therapeutic implications which arise. These individuals have a defect in the way that sodium intake modifies adrenal and renal vascular responses to angiotensin II, resulting in an abnormality in sodium handling. Angiotensin converting enzyme (ACE) inhibitors partially, if not completely, correct this underlying defect and thereby reduce blood pressure by restoring the renal vascular responsiveness to normal. Because of the specificity of ACE inhibitors in treating non-modulators, it is to be expected that they would produce fewer long term side effects, resulting in a better quality of life for these patients than if their blood pressures were treated non-specifically.
Similar articles
- Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension.
Williams GH, Hollenberg NK. Williams GH, et al. J Hypertens Suppl. 1984 Dec;2(2):S43-7. J Hypertens Suppl. 1984. PMID: 6100876 - Renal abnormalities in nonmodulating essential hypertension.
Williams GH, Moore TJ, Hollenberg NK. Williams GH, et al. Am J Kidney Dis. 1987 Jul;10(1 Suppl 1):39-44. Am J Kidney Dis. 1987. PMID: 3037888 - Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
Hollenberg NK, Williams GH. Hollenberg NK, et al. Kidney. 1988 Nov;21(3):13-8. Kidney. 1988. PMID: 11538850 Review. - Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S. Salvetti A, et al. Int J Clin Pharmacol Res. 1985;5(6):429-38. Int J Clin Pharmacol Res. 1985. PMID: 3005182 Review.
Cited by
- Genetics of Human Primary Hypertension: Focus on Hormonal Mechanisms.
Manosroi W, Williams GH. Manosroi W, et al. Endocr Rev. 2019 Jun 1;40(3):825-856. doi: 10.1210/er.2018-00071. Endocr Rev. 2019. PMID: 30590482 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous